Rocket LabRKLB

Business Snapshot

• Rocket Lab Corporation (NASDAQ: RKLB) is a U.S.-listed common stock. The payload does not provide a sector or industry classification.
• The stock closed at $72.57. The reported session range was unusually wide: $37.57–$151.00.
• Over the provided 200-day daily-bar window, price moved from $57.80 to $72.57, a gain of 25.55%, but it remains below the reported 200-day high of $151.00.
• The company has expanded its balance sheet substantially, with cash and equivalents reaching $2.129 billion as of June 30, 2026. However, the operating business remains loss-making and free-cash-flow negative.

Financial Trends

• Revenue trajectory: Reported revenue increased from $155.080 million in Q3 2025 to $200.348 million in Q1 2026, then to $234.066 million in Q2 2026. Q2 revenue rose $33.718 million, or 16.8%, sequentially from Q1 and $78.986 million, or 50.9%, versus Q3 2025. The reported $601.799 million for Q4 2025 is a 10-K period and is not directly comparable to the quarterly figures without additional filing context.
• Gross profit and margin: Gross profit increased from $57.314 million in Q3 2025 to $76.493 million in Q1 2026 and $84.576 million in Q2 2026. Q2 gross profit rose 10.6% sequentially. Gross margin, however, declined from 38.18% in Q1 to 36.13% in Q2, a 2.05 percentage-point contraction. It was still slightly below Q3 2025’s 36.96%.
• Operating performance: Operating losses improved from $58.969 million in Q3 2025 to $55.969 million in Q1 2026 and $57.514 million in Q2 2026. The Q2 loss widened $1.545 million sequentially, while operating margin improved substantially from -38.02% in Q3 2025 to -27.94% in Q1 2026 and -24.57% in Q2. This indicates operating leverage relative to revenue, despite the modest sequential deterioration in dollars.
• Net income: Net loss was $18.257 million in Q3 2025, $45.022 million in Q1 2026, and $49.258 million in Q2 2026. Q2’s loss widened $4.236 million, or 9.4%, sequentially. Net margin improved from -32.94% in Q4 2025 to -22.47% in Q1 and -21.04% in Q2, but remains deeply negative.
• Free cash flow: FCF deteriorated sequentially from -$77.397 million in Q1 2026 to -$187.519 million in Q2, a deterioration of $110.122 million. Compared with Q3 2025’s -$207.621 million, Q2 FCF was better by $20.102 million, but the latest quarter shows a renewed acceleration in cash consumption. Capital expenditures also increased from $27.065 million in Q1 to $53.112 million in Q2.
• Operating cash flow: Cash from operations declined from -$50.332 million in Q1 to -$134.407 million in Q2. The latest operating cash outflow is worse than Q3 2025’s -$100.990 million, indicating weaker near-term cash conversion.
• Cash and liquidity: Cash increased from $807.875 million in Q3 2025 to $2.129 billion in Q2 2026, a gain of $1.322 billion. Most of that balance-sheet expansion coincided with substantial financing inflows: $881.734 million in Q3 2025, $1.071 billion in Q4, $463.293 million in Q1, and $1.523 billion in Q2. The data therefore points to financing as a major driver of cash growth rather than internally generated cash.
• Balance-sheet strength: Current assets increased from $1.316 billion to $2.896 billion, while current liabilities rose from $414.457 million to $528.196 million. The current ratio improved from 3.18x to 5.48x, and working capital increased from $901.966 million to $2.368 billion. Long-term debt declined from $51.267 million to $1.716 million. These are significant improvements in liquidity and leverage.
• Dilution: Shares outstanding increased from 496.2 million in Q3 2025 to 598.2 million in Q2 2026, an increase of approximately 20.5%. Diluted weighted-average shares rose from 528.7 million to 629.7 million over the same comparison. The stronger cash position has therefore come alongside meaningful share-count expansion.

Financial Health

• The latest balance sheet is strong from a liquidity perspective: $2.129 billion of cash, $2.896 billion of current assets, and only $1.716 million of long-term debt. A 5.48x current ratio provides a substantial near-term liquidity cushion.
• The principal financial risk is not leverage but continued cash burn and dilution. Q2 operating cash flow was -$134.407 million, and FCF was -$187.519 million. Financing inflows of $1.523 billion materially exceeded operating cash outflows, so cash growth should not be interpreted as evidence of self-funded operations.
• Profitability is improving on a margin basis: operating margin moved from approximately -38% in Q3/Q4 2025 to -24.57% in Q2 2026. However, gross margin slipped sequentially and both operating income and net income remained negative.
• Inventory rose from $144.999 million to $266.931 million across the four reported periods, an increase of approximately 84%. This may support future activity, but it also represents capital tied up in inventory; the payload does not provide inventory-turnover or backlog data.
• Share count rose materially while retained earnings remained negative, reaching -$1.106 billion in Q2. The company therefore has balance-sheet capacity, but investors must weigh that strength against ongoing losses, negative FCF, and dilution.

Insider Activity

• Insider sentiment for May 25–August 23, 2026 is classified as Neutral (-10).
• Reported activity included $319.277 million of sales across 49 transactions and no purchases across four transactions, producing net insider activity of -$319.277 million.
• The available transaction detail includes an August 17 sale of 30,000 shares attributed to Adam C. Spice, reported at $0.00 total value and $0.00 per share. Because the filing data shows a zero price, its economic interpretation is unclear.
• The aggregate data is a negative sentiment signal because sales substantially outweighed purchases, but the payload does not identify whether the sales were open-market transactions, automatic plans, tax-related transactions, or equity-compensation dispositions.

Multi-Timeframe Technical Context

• Only daily technical data is provided; intraday 1-minute through hourly indicators are unavailable. The ultra-short and short-horizon observations are therefore limited to the daily chart and current reported volume.
• Ultra-short horizon — minutes: The stock closed at $72.57 after an exceptionally broad reported session range of $37.57–$151.00. This range indicates extreme near-term volatility or a potentially anomalous data print. Current volume of 12.57 million was below the 20-day average of 18.68 million, suggesting no volume confirmation for a strong closing breakout.
• Short horizon — hours to days: RSI-14 was 53.7 and RSI-21 was 52.22, both near neutral and not indicating an overbought or oversold condition. MACD was -0.8868, below zero, but above its signal line of -1.3255, which indicates negative momentum with a modest bullish improvement.
• Price was below the 12-day EMA of $76.28, 26-day EMA of $77.17, 20-day SMA of $74.07, 50-day SMA of $82.05, and 200-day SMA of $78.73. This leaves the broader daily trend technically below key moving-average resistance.
• Bollinger Bands were positioned at $59.92 lower, $74.07 middle, and $88.22 upper. At $72.57, price was just below the middle band. ATR was $5.43, implying substantial typical daily movement relative to the share price.
• Long horizon — weeks to months: The 200-bar move is positive at +25.55%, but price remains below the 50-day and 200-day averages. A sustained move above approximately $78.73–$82.05 would improve the longer-term technical structure; continued trading below those levels keeps the chart mixed rather than decisively bullish.

Bull / Bear Cases

• Short-term bull case: Neutral RSI, MACD above its signal line, and price near the Bollinger middle band leave room for a rebound. A move above the $74.07–$77.17 area could signal recovery toward the $82.05 50-day average and potentially the $88.22 upper Bollinger Band.
• Short-term bear case: Price remains below all listed short-, medium-, and long-term moving averages, while volume is below its 20-day average. Failure to reclaim $74–$77 could preserve downside momentum, with the $59.92 lower Bollinger Band as a technical downside reference. The reported session low of $37.57 highlights the severity of potential volatility, although that print should be treated cautiously given the unusually wide range.
• Long-term bull case: Revenue has grown sequentially from $155.080 million in Q3 2025 to $234.066 million in Q2 2026, while operating margin improved from roughly -38% to -24.57%. The company also has substantial liquidity, minimal reported long-term debt, and a current ratio above 5x, giving it financial flexibility to fund operations and investment.
• Long-term bear case: The business remains unprofitable and FCF-negative, with Q2 FCF worsening to -$187.519 million and operating cash flow falling to -$134.407 million. Cash growth was accompanied by large financing inflows and approximately 20.5% growth in shares outstanding from Q3 2025 to Q2 2026. Gross margin also declined sequentially, and insider activity was heavily weighted toward selling. Without additional data on backlog, launch cadence, guidance, valuation, or cash runway, the fundamental upside case cannot be quantified.

Key Levels & Triggers

• $74.07: Daily SMA-20 and Bollinger middle band. Reclaiming and holding this level would be an initial short-term improvement.
• $76.28–$77.17: EMA-12 and EMA-26 resistance zone. A decisive move above this area would strengthen near-term momentum.
• $78.73: SMA-200. Recovery above this level would improve the long-term technical posture.
• $82.05: SMA-50. A breakout above this level would confirm a stronger trend reversal and could open a test of $88.22.
• $59.92: Lower Bollinger Band and an important downside reference if the stock loses the low-$70s area.
• Bullish triggers: Reclaim of $74–$77, followed by sustained trade above $78.73–$82.05, ideally with volume exceeding the 18.68 million 20-day average.
• Bearish triggers: Rejection below the moving-average cluster, a break under $59.92, continued deterioration in FCF, or further financing-driven dilution.
• Fundamental monitoring: Future periods should be assessed for whether revenue growth continues, gross margin recovers from 36.13%, operating losses narrow in dollars, and FCF improves without relying primarily on new financing.